Research indicates that women may experience a higher incidence of gastrointestinal side effects compared to men, making it essential for them to approach these treatments with caution
Oxidative stress and disuse muscle atrophy: cause or consequence
The small proportion of participants in the subgroup with baseline SGLT2 inhibitor use (6.1% in Harmony Outcomes and 8.8% in the meta-analysis) reduced the precision of the treatment effect estimates and the statistical power of the interaction tests
AOD-9604 Trial Data (Efficacy, Adverse Events) AOD-9604 was studied across six randomized, double-blind, placebo-controlled trials involving roughly 900 participants between 2001 and 2006, making it one of the more extensively studied peptide fragments in human research
Semaglutide GLP-1 S, on the other hand, is studied within a much broader and more validated use case, with trial data reporting average body weight reductions exceeding 14% over 68 weeks a proof point that has made GLP-1 receptor agonists a far more established research category for metabolic and weight-related studies than growth hormone fragment peptides like AOD-9604